Review



biofire rp2.1 panel  (BioFire Defense)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    BioFire Defense biofire rp2.1 panel
    Biofire Rp2.1 Panel, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biofire+rp2%2E1+panel/pm40392438-150-2-2?v=BioFire+Defense
    Average 90 stars, based on 1 article reviews
    biofire rp2.1 panel - by Bioz Stars, 2026-07
    90/100 stars

    Images



    Similar Products

    biofire rp2.1 panel  (BioFire Defense)
    90
    BioFire Defense biofire rp2.1 panel
    Biofire Rp2.1 Panel, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biofire+rp2%2E1+panel/pm40392438-150-2-2?v=BioFire+Defense
    Average 90 stars, based on 1 article reviews
    biofire rp2.1 panel - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    film array respiratory panel biofire® rp2.1  (BioFire Defense)
    90
    BioFire Defense film array respiratory panel biofire® rp2.1
    Film Array Respiratory Panel Biofire® Rp2.1, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biofire+rp2%2E1+panel/pm40065003-45-33-37?v=BioFire+Defense
    Average 90 stars, based on 1 article reviews
    film array respiratory panel biofire® rp2.1 - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    film array respiratory panel biofire rp2.1  (BioFire Defense)
    90
    BioFire Defense film array respiratory panel biofire rp2.1
    Film Array Respiratory Panel Biofire Rp2.1, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biofire+rp2%2E1+panel/pm40065003-3-13-17?v=BioFire+Defense
    Average 90 stars, based on 1 article reviews
    film array respiratory panel biofire rp2.1 - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    biofire-rp2.1 multiplex panel test  (BioFire Defense)
    90
    BioFire Defense biofire-rp2.1 multiplex panel test
    Biofire Rp2.1 Multiplex Panel Test, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biofire+rp2%2E1+panel/pm39711468-104-6-6?v=BioFire+Defense
    Average 90 stars, based on 1 article reviews
    biofire-rp2.1 multiplex panel test - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    biofire-rp2.1 multiplex panel tests  (BioFire Defense)
    90
    BioFire Defense biofire-rp2.1 multiplex panel tests
    Biofire Rp2.1 Multiplex Panel Tests, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biofire+rp2%2E1+panel/pm39711468-69-20-17?v=BioFire+Defense
    Average 90 stars, based on 1 article reviews
    biofire-rp2.1 multiplex panel tests - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    biofire-rp2.1 multiplex panel  (BioFire Defense)
    90
    BioFire Defense biofire-rp2.1 multiplex panel
    Biofire Rp2.1 Multiplex Panel, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biofire+rp2%2E1+panel/pm39711468-83-11-9?v=BioFire+Defense
    Average 90 stars, based on 1 article reviews
    biofire-rp2.1 multiplex panel - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    respiratory multiplex panel version 2.1 (biofire‐rp2.1  (BioFire Defense)
    90
    BioFire Defense respiratory multiplex panel version 2.1 (biofire‐rp2.1
    Respiratory pathogen detection by <t>BioFire‐RP2.1</t> and QIAstat‐Dx‐RP2.0 multiplex panel tests. (A) Detection of respiratory pathogens in 269 respiratory samples from 259 patients using BioFire‐RP2.1 (orange) and QIAstat‐Dx‐RP2.0 (blue) between November 2023 and February 2024. (B) Age distribution of patients who tested positive for the respective respiratory pathogens (median, 25% and 75%). (C) Respiratory pathogen loads in patient samples that tested positive with both the BioFire‐RP2.1 and QIAstat‐Dx‐RP2.0 (yellow), or were detected exclusively in one of the multiplex panel tests (red; median, 25% and 75%). p values of the Mann‐Whitney U ‐test, with a single asterisk (*) indicating a significance level of less than 0.05, a double asterisk (**) indicating a significance level of less than 0.01, and a triple asterisk (***) indicating a significance level of less than 0.001. HAdV, adenovirus (HAdV); HBoV, human bocavirus; HCoV, human coronavirus (types ‐229E, ‐HKU1, ‐NL63 and ‐OC43); hMPV, human metapneumovirus A and B; HPIV, human parainfluenzavirus; HRV/HEV, human rhino‐/enterovirus; IV‐A, influenzavirus A; IV‐B, influenzavirus B; M. pneu, Mycoplasma pneumoniae ; MERS, Middle East respiratory syndrome coronavirus; RSV, respiratory syncytial virus A and B (RSV); SCoV2/SARS‐CoV‐2, severe respiratory syndrome coronavirus.
    Respiratory Multiplex Panel Version 2.1 (Biofire‐Rp2.1, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biofire+rp2%2E1+panel/pmc11664495-92-5-10?v=BioFire+Defense
    Average 90 stars, based on 1 article reviews
    respiratory multiplex panel version 2.1 (biofire‐rp2.1 - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Respiratory pathogen detection by BioFire‐RP2.1 and QIAstat‐Dx‐RP2.0 multiplex panel tests. (A) Detection of respiratory pathogens in 269 respiratory samples from 259 patients using BioFire‐RP2.1 (orange) and QIAstat‐Dx‐RP2.0 (blue) between November 2023 and February 2024. (B) Age distribution of patients who tested positive for the respective respiratory pathogens (median, 25% and 75%). (C) Respiratory pathogen loads in patient samples that tested positive with both the BioFire‐RP2.1 and QIAstat‐Dx‐RP2.0 (yellow), or were detected exclusively in one of the multiplex panel tests (red; median, 25% and 75%). p values of the Mann‐Whitney U ‐test, with a single asterisk (*) indicating a significance level of less than 0.05, a double asterisk (**) indicating a significance level of less than 0.01, and a triple asterisk (***) indicating a significance level of less than 0.001. HAdV, adenovirus (HAdV); HBoV, human bocavirus; HCoV, human coronavirus (types ‐229E, ‐HKU1, ‐NL63 and ‐OC43); hMPV, human metapneumovirus A and B; HPIV, human parainfluenzavirus; HRV/HEV, human rhino‐/enterovirus; IV‐A, influenzavirus A; IV‐B, influenzavirus B; M. pneu, Mycoplasma pneumoniae ; MERS, Middle East respiratory syndrome coronavirus; RSV, respiratory syncytial virus A and B (RSV); SCoV2/SARS‐CoV‐2, severe respiratory syndrome coronavirus.

    Journal: Journal of Medical Virology

    Article Title: Multicenter Evaluation of the QIAstat‐Dx and the BioFire Multiplex Panel Tests for the Detection of Respiratory Pathogens

    doi: 10.1002/jmv.70129

    Figure Lengend Snippet: Respiratory pathogen detection by BioFire‐RP2.1 and QIAstat‐Dx‐RP2.0 multiplex panel tests. (A) Detection of respiratory pathogens in 269 respiratory samples from 259 patients using BioFire‐RP2.1 (orange) and QIAstat‐Dx‐RP2.0 (blue) between November 2023 and February 2024. (B) Age distribution of patients who tested positive for the respective respiratory pathogens (median, 25% and 75%). (C) Respiratory pathogen loads in patient samples that tested positive with both the BioFire‐RP2.1 and QIAstat‐Dx‐RP2.0 (yellow), or were detected exclusively in one of the multiplex panel tests (red; median, 25% and 75%). p values of the Mann‐Whitney U ‐test, with a single asterisk (*) indicating a significance level of less than 0.05, a double asterisk (**) indicating a significance level of less than 0.01, and a triple asterisk (***) indicating a significance level of less than 0.001. HAdV, adenovirus (HAdV); HBoV, human bocavirus; HCoV, human coronavirus (types ‐229E, ‐HKU1, ‐NL63 and ‐OC43); hMPV, human metapneumovirus A and B; HPIV, human parainfluenzavirus; HRV/HEV, human rhino‐/enterovirus; IV‐A, influenzavirus A; IV‐B, influenzavirus B; M. pneu, Mycoplasma pneumoniae ; MERS, Middle East respiratory syndrome coronavirus; RSV, respiratory syncytial virus A and B (RSV); SCoV2/SARS‐CoV‐2, severe respiratory syndrome coronavirus.

    Article Snippet: Among those are the BioFire respiratory multiplex panel version 2.1 (BioFire‐RP2.1) and the QIAstat‐Dx respiratory panel version 2.0 (QIAstat‐Dx‐RP2.0), generating results from 23 different respiratory targets, including SARS‐CoV‐2 in approximately 1 h. In this prospective multicenter study, we conducted a comparative evaluation of the BioFire‐RP2.1 and QIAstat‐Dx‐RP2.0 multiplex panel tests using 269 respiratory clinical specimens, prospectively collected from patients with RTIs.

    Techniques: Multiplex Assay, MANN-WHITNEY, Virus

    Percent agreement and Cohen's kappa score for the comparison of BioFire‐RP2.1 and QIAstat‐Dx‐RP2.0 multiplex panel tests in 269 respiratory clinical specimens.

    Journal: Journal of Medical Virology

    Article Title: Multicenter Evaluation of the QIAstat‐Dx and the BioFire Multiplex Panel Tests for the Detection of Respiratory Pathogens

    doi: 10.1002/jmv.70129

    Figure Lengend Snippet: Percent agreement and Cohen's kappa score for the comparison of BioFire‐RP2.1 and QIAstat‐Dx‐RP2.0 multiplex panel tests in 269 respiratory clinical specimens.

    Article Snippet: Among those are the BioFire respiratory multiplex panel version 2.1 (BioFire‐RP2.1) and the QIAstat‐Dx respiratory panel version 2.0 (QIAstat‐Dx‐RP2.0), generating results from 23 different respiratory targets, including SARS‐CoV‐2 in approximately 1 h. In this prospective multicenter study, we conducted a comparative evaluation of the BioFire‐RP2.1 and QIAstat‐Dx‐RP2.0 multiplex panel tests using 269 respiratory clinical specimens, prospectively collected from patients with RTIs.

    Techniques: Comparison, Multiplex Assay

    Diagnostic performance of the QIAstat‐Dx‐RP2.0 compared to the BioFire‐RP2.1 multiplex panel test.

    Journal: Journal of Medical Virology

    Article Title: Multicenter Evaluation of the QIAstat‐Dx and the BioFire Multiplex Panel Tests for the Detection of Respiratory Pathogens

    doi: 10.1002/jmv.70129

    Figure Lengend Snippet: Diagnostic performance of the QIAstat‐Dx‐RP2.0 compared to the BioFire‐RP2.1 multiplex panel test.

    Article Snippet: Among those are the BioFire respiratory multiplex panel version 2.1 (BioFire‐RP2.1) and the QIAstat‐Dx respiratory panel version 2.0 (QIAstat‐Dx‐RP2.0), generating results from 23 different respiratory targets, including SARS‐CoV‐2 in approximately 1 h. In this prospective multicenter study, we conducted a comparative evaluation of the BioFire‐RP2.1 and QIAstat‐Dx‐RP2.0 multiplex panel tests using 269 respiratory clinical specimens, prospectively collected from patients with RTIs.

    Techniques: Diagnostic Assay, Multiplex Assay, Bacteria

    Co‐detections of respiratory pathogens by BioFire‐RP2.1 and QIAstat‐Dx‐RP2.0.

    Journal: Journal of Medical Virology

    Article Title: Multicenter Evaluation of the QIAstat‐Dx and the BioFire Multiplex Panel Tests for the Detection of Respiratory Pathogens

    doi: 10.1002/jmv.70129

    Figure Lengend Snippet: Co‐detections of respiratory pathogens by BioFire‐RP2.1 and QIAstat‐Dx‐RP2.0.

    Article Snippet: Among those are the BioFire respiratory multiplex panel version 2.1 (BioFire‐RP2.1) and the QIAstat‐Dx respiratory panel version 2.0 (QIAstat‐Dx‐RP2.0), generating results from 23 different respiratory targets, including SARS‐CoV‐2 in approximately 1 h. In this prospective multicenter study, we conducted a comparative evaluation of the BioFire‐RP2.1 and QIAstat‐Dx‐RP2.0 multiplex panel tests using 269 respiratory clinical specimens, prospectively collected from patients with RTIs.

    Techniques:

    Co‐detection of respiratory pathogens by BioFire‐RP2.1 and QIAstat‐Dx‐RP2.0 multiplex panel tests. (A) Number of single detections, and the co‐detection of two or three respiratory pathogens in the same patient sample using BioFire‐RP2.1 (orange) and QIAstat‐Dx‐RP2.0 (blue). Comparison of co‐detection of respiratory pathogens by percent agreement. B. Age distribution of patients who tested positive for a single, two or three respiratory pathogens in the same patient sample (median, 25% and 75%). C. Respiratory pathogen loads in patient samples with a single detection, and the co‐detection of two or three respiratory pathogens (median, 25% and 75%). p values of the Mann‐Whitney U‐test indicate a statistically significant difference when compared to single respiratory pathogen detection. A single asterisk (*) denotes a significance level of less than 0.05, and a double asterisk (**) indicates a significance level of less than 0.01.

    Journal: Journal of Medical Virology

    Article Title: Multicenter Evaluation of the QIAstat‐Dx and the BioFire Multiplex Panel Tests for the Detection of Respiratory Pathogens

    doi: 10.1002/jmv.70129

    Figure Lengend Snippet: Co‐detection of respiratory pathogens by BioFire‐RP2.1 and QIAstat‐Dx‐RP2.0 multiplex panel tests. (A) Number of single detections, and the co‐detection of two or three respiratory pathogens in the same patient sample using BioFire‐RP2.1 (orange) and QIAstat‐Dx‐RP2.0 (blue). Comparison of co‐detection of respiratory pathogens by percent agreement. B. Age distribution of patients who tested positive for a single, two or three respiratory pathogens in the same patient sample (median, 25% and 75%). C. Respiratory pathogen loads in patient samples with a single detection, and the co‐detection of two or three respiratory pathogens (median, 25% and 75%). p values of the Mann‐Whitney U‐test indicate a statistically significant difference when compared to single respiratory pathogen detection. A single asterisk (*) denotes a significance level of less than 0.05, and a double asterisk (**) indicates a significance level of less than 0.01.

    Article Snippet: Among those are the BioFire respiratory multiplex panel version 2.1 (BioFire‐RP2.1) and the QIAstat‐Dx respiratory panel version 2.0 (QIAstat‐Dx‐RP2.0), generating results from 23 different respiratory targets, including SARS‐CoV‐2 in approximately 1 h. In this prospective multicenter study, we conducted a comparative evaluation of the BioFire‐RP2.1 and QIAstat‐Dx‐RP2.0 multiplex panel tests using 269 respiratory clinical specimens, prospectively collected from patients with RTIs.

    Techniques: Multiplex Assay, Comparison, MANN-WHITNEY